# FDA Inspection 1206225 - Progenics Pharmaceuticals, Inc. - April 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/progenics-pharmaceuticals-inc/ee9d71d5-26ba-4fae-a94d-faf934f4291e
Source feed: FDA_Inspections

> FDA Inspection 1206225 for Progenics Pharmaceuticals, Inc. on April 21, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206225
- Company Name: Progenics Pharmaceuticals, Inc.
- Inspection Date: 2023-04-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1121240 - 2020-03-20](https://www.keypedia.com/records/fda_inspections/progenics-pharmaceuticals-inc/50e04dbd-417c-4069-afcc-c970d5d2bd17)

Company: https://www.keypedia.com/companies/progenics-pharmaceuticals-inc/af57a549-061b-40d6-b52b-e1ce51283389

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c